16 / 112
14
WFSBP 2015
Scientific Programme Overview
|
Monday, 15 June 2015
Trianti
Mitropoulos
Skalkotas
MC 3
MC 2
8:30
S-01
Advances in child
psychiatry research
S-02
A better use of antipsy
chotics to improve the
prognosis of schizo
phrenia
S-19
Serotonin and
neuroplasticity
S-04
Alcohol, nicotine and
metamphetamine
addiction, progress at
basic and clinical fronts
S-05
Sex differences in the
neurobiology of fear
and anxiety: A trans
lational approach
9:00
9:30
10:00
PL-01
DSM, ICD and
RDoc and the future of
psychiatric diagnosis
10:30
Break
11:00
RT-01
Drug discovery in
neuroscience: Why is
big pharma reluctant to
continue investing?
S-52
Identifying biomarkers
of treatment outcome
in depression: Canadian
network for biomarker
integration in depres
sion
S-38
New challenges in
psychoactive sub
stances and addictions
treatments
TG-01
Task Force on Bipolar
Disorders: Improving
longitudinal treatment
for bipolar disorders
including mixed states
guidelines
S-08
Behavioral addictions:
Diagnosis, co-morbi
dity and neurobiology
11:30
12:00
12:30
Break
13:00
FC-03
Antidepressants
FC-04
Dementia
FC-05
Genetics
FC-06
Eating / Sleeping / Perso
nality Disorders
13:30
14:00
14:30
Break
15:00
S-11
Biological overlaps
between schizophrenia
and autism spectrum
disorders: Neuroima
ging and neurophysi
ology
S-12
Epigenetic acquisitions
in mood disorders: Im
plication for pathophy
siology and treatment
TG-02
Task Force
on Genetics
S-13
Identifying the biologi
cal targets of treatment
response to neuromo
dulation in resistant
psychiatric disorders
S-14
Neuron-Glia inter
actions and neuro
psychiatric disease:
Implications for novel
therapeutics
15:30
16:00
16:30
FC-09
Depression
WS-01
Lithium phobia:
Science or superstition?
WS-02
Mood disorders and
bipolar spectrum: How
to get over diagnostic
problems
WS-03
Neurocognitive and
functional impairment
in mood disorders
17:00
SA-02
Industry sponsored
symposium
17:30
18:00
18:30
Hall
Time